Stylage® L (2 x 1.0 mL) | Laboratoires VIVACY

Short Description

A high-viscosity, deep-action Hyaluronic Acid dermal filler formulated with 24 mg/g of cross-linked HA, patented IPN-Like technology, and the antioxidant Mannitol. Specifically calibrated for deep dermal placement, Stylage® L is engineered to correct severe-to-deep facial folds, efface prominent nasolabial and marionette lines, and restore lost volume to the dorsum of the hands with smooth tissue integration lasting up to 12 months.

Detailed Description

Stylage® L is an advanced, sterile, non-pyrogenic physiological cross-linked sodium hyaluronate dermal implant developed by Laboratoires VIVACY (France). Utilizing VIVACY’s proprietary IPN-Like Technology (InterPenetrated Cross-Linked Networks), it combines two distinct monophasic cross-linked HA networks. This molecular architecture provides high elasticity and robust resistance to dynamic shear stress, allowing the gel to lift deep dermal depressions without migrating or creating unnatural palpable ridges.

Formulated with Mannitol, a natural antioxidant and free-radical scavenger, Stylage L actively neutralizes reactive oxygen species (ROS) triggered by mechanical needle and cannula passes during injection. By shielding the hyaluronic acid chains from acute oxidative degradation, Mannitol significantly minimizes post-procedure edema, erythema, and downtime. Delivered in VIVACY’s ergonomic Bi-Soft® syringe system, Stylage L offers injectors maximum extrusion precision and ergonomic control across dense fibrous planes.

Treatment Areas & Indications

• Severe-to-Deep Facial Folds & Creases:

  • Deep nasolabial folds (smile lines extending from the nose to the oral commissures)

  • Severe marionette lines and profound oral commissure descent

  • Deep labiomental furrow (mental crease between lower lip and chin)

• Dorsal Hand Rejuvenation:

  • Restoring lost subcutaneous volume on the back of the hands (dorsum)

  • Concealing prominent superficial veins, tendons, and skeletal structures

• Facial Contouring & Touch-Ups:

  • Chin crease effacement and mild mandibular border contouring

  • Deep atrophic scar tissue elevation

Key Clinical Advantages

• Patented IPN-Like Technology: Provides high cohesive density and elasticity ($G’$), generating the structural lift needed to push out deep cutaneous folds while maintaining natural dynamic facial movement.

• Mannitol Free-Radical Protection: Decreases acute post-treatment swelling, bruising, and erythema, ensuring immediate comfort and protecting the gel against early enzymatic breakdown.

• Approved for Hand Rejuvenation: Clinically proven and widely favored for deep subcutaneous hand bio-volumization, offering natural tissue spreading without visible bolus contours.

• Ergonomic Bi-Soft® Syringe Delivery: Features an optimized center of gravity, non-slip textured wings, and smooth plunger mechanics that noticeably reduce injection force in dense tissue planes.

• Available with Lidocaine: Formulated in both standard and lidocaine-infused presentations (Stylage L with Lidocaine 0.3%) to optimize patient comfort during deep dermal administration.

• Reliable Longevity: High resistance to endogenous hyaluronidase yields sustained corrective durability for up to 12 months.

Technical Specifications

Professional Advisory: Stylage® L is a medical-grade injectable device restricted strictly to certified dermatologists, plastic surgeons, and credentialed aesthetic physicians skilled in deep dermal and subdermal injection techniques. Not intended for superficial dermal injection or non-clinical consumer use.